Search Videos and More
Narjust Florez, MD Discusses Young Lung Cancer
Lung cancer rates in younger adults are rising. Dana-Farber's Narjust Florez, MD discusses research showing that young patients with lung cancer face ample financial toxicity and issues impacting physical, emotional, and functional well-being.Narjust Florez, MD Discusses International Medical Graduate Challenges
1 out of 4 doctors in the United States graduated from international medical schools, yet according to a study presented at ASCO24, these doctors remain victims of discrimination at frequent rates.Jia Luo, MD Discusses NUT Carcinoma
NUT Carcinoma may not be as rare as one thought. Jia Luo, MD, of Dana-Farber, shares new efforts to research this type of rare cancer that can grow anywhere in the body, often in the head, neck and lungs.Kenneth Kehl, MD, MPH Reviews Artificial Intelligence and Genomic Data
Using artificial intelligence to link genomic data to clinical outcomes in cancer care across institutions without compromising protected health information is challenging.Study Identifies Novel Target for Pediatric Neuroblastoma
Researchers at Dana-Farber Cancer Institute have identified a protein complex that is required for the growth of a high-risk form of childhood brain cancer called MYCN-amplified neuroblastoma.Research Provides New Insights Into ‘Infernal’ Mode of Cell Death
A group of scientists at Dana-Farber have trained their attention on an ancient family of proteins, called gasdermins, that punch holes, or pores, in the cell membrane during pyroptosis.Telehealth Can Significantly Reduce Greenhouse Gas Emissions Associated with Cancer Care, Study Finds
Telemedicine visits for cancer care may not only be more convenient and easier to schedule than in-person appointments, they're also better for the planet, new research by Dana-Farber Cancer Institute scientists shows.AACR 2024 Highlights
Review presentations and information shared by Dana-Farber physician-scientists at the 2024 American Association of Cancer Research (AACR) Annual Meeting held April 5-10, San Diego, CA.Science Behind Targeted Drug for Pediatric Brain Cancer Has Dana-Farber Roots
Two separate research teams had discovered a genetic driver for the most common of childhood brain tumors called pediatric low-grade glioma.Dana-Farber Researchers Discover New Target for Potential Leukemia Therapy
A team of Dana-Farber Cancer Institute investigators discovered that a subset of myeloid and lymphoid leukemias depend on a molecular complex called PI3Kgamma for survival.Most Young Women Treated For Breast Cancer Can Have Children, Study Shows
In a study of nearly 200 young women who have survived breast cancer, most of those who tried to conceive were able to become pregnant and give birth.2024 American Society of Clinical Oncology (ASCO)
Review presentations, oral abstracts, and other information shared by Dana-Farber physician-scientists at the ASCO 2024 Annual Meeting.